Value creation in the pharmaceutical industry : the critical path to innovation / edited by Alexander Schuhmacher, Markus Hinder and Oliver Gassmann.
Material type:
- text
- computer
- online resource
- 9783527693412 (e-book)
- 9783527693436 (e-book)
- 338.476151 23
- HD9665.5 .V354 2016
Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|
![]() |
Colombo | Available | CBERA10001296 | ||||
![]() |
Jaffna | Available | JFEBRA10001296 | ||||
![]() |
Kandy | Available | KDEBRA10001296 |
Enhanced descriptions from Syndetics:
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation.
A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes.
A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Includes bibliographical references at the end of each chapters and index.
Description based on online resource; title from PDF title page (ebrary, viewed January 22, 2016).
Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
There are no comments on this title.